Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kaletra”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT01738555
What this trial is testing

A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects

Who this might be right for
Human Immunodeficiency Virus Infection
RFS Pharma, LLC
Large-scale testing (Phase 3)Study completedNCT00272779
What this trial is testing

BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada

Who this might be right for
HIV Infections
Bristol-Myers Squibb 1,057
Large-scale testing (Phase 3)UnknownNCT04403100
What this trial is testing

Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: "The Hope Coalition - 1"

Who this might be right for
COVID-19Coronavirus InfectionVirus Disease+2 more
Cardresearch 1,968
Large-scale testing (Phase 3)UnknownNCT04321174
What this trial is testing

COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir

Who this might be right for
Coronavirus InfectionsPost-exposure Prophylaxis
Unity Health Toronto 123
Post-approval studies (Phase 4)Study completedNCT00159224
What this trial is testing

Induction-maintenance of Lopinavir/r in HIV-infected Subjects

Who this might be right for
HIV Infections
Fundación Huésped 100
Testing effectiveness (Phase 2)Study completedNCT00802334
What this trial is testing

TDM of Generic Lopinavir/Ritonavir 200/50 mg

Who this might be right for
HIV
The HIV Netherlands Australia Thailand Research Collaboration 70
Not applicableStudy completedNCT04376814
What this trial is testing

Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19

Who this might be right for
COVID-19FavipiravirKaletra+2 more
Baqiyatallah Medical Sciences University 40
Large-scale testing (Phase 3)Study completedNCT00640263
What this trial is testing

Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 1,500
Early research (Phase 1)Study completedNCT00266058
What this trial is testing

Drug Interaction Study Between Antimalarial and Anti-HIV Medications

Who this might be right for
HIV InfectionsMalaria
University of California, San Francisco 33
Large-scale testing (Phase 3)Ended earlyNCT00409591
What this trial is testing

Maternal/Infant Peripartum NVP, Versus Infant Only Peripartum NVP, or Maternal LPV/r in Addition to Standard ZDV Prophylaxis for the Prevention of Perinatal (PMTCT) HIV in Thailand

Who this might be right for
HIV InfectionsPregnancy
Institut de Recherche pour le Developpement 435
Large-scale testing (Phase 3)Study completedNCT00135395
What this trial is testing

A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen

Who this might be right for
HIV Infections
Bristol-Myers Squibb 200
Post-approval studies (Phase 4)Study completedNCT00627055
What this trial is testing

Second-line Therapy Antiretroviral in Patients Who Failed Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) - Based Regimens

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 200
Early research (Phase 1)Study completedNCT01660477
What this trial is testing

Drug-drug Interaction Study Between Lopinavir/Ritonavir and Isavuconazole

Who this might be right for
Pharmacokinetics of IsavuconazolePharmacokinetics of Lopinavir/RitonavirHealthy Volunteers
Astellas Pharma Global Development, Inc. 68
Large-scale testing (Phase 3)Ended earlyNCT04328285
What this trial is testing

Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers

Who this might be right for
COVID-19
Centre Hospitalier Universitaire de Saint Etienne 118
Not applicableStudy completedNCT01294761
What this trial is testing

Comparing Continuing Tenofovir, Emtricitabine (or Lamivudine) Plus Lopinavir and Switching to Raltegravir Plus Darunavir

Who this might be right for
HIV Infections
National Center for Global Health and Medicine, Japan 59
Large-scale testing (Phase 3)Ended earlyNCT00443729
What this trial is testing

MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-033)(TERMINATED)

Who this might be right for
HIV Infection
Merck Sharp & Dohme LLC 355
Testing effectiveness (Phase 2)Study completedNCT00752856
What this trial is testing

Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine in Treatment Naive Patients

Who this might be right for
HIV Infections
University of California, San Diego 51
Large-scale testing (Phase 3)Study completedNCT00988039
What this trial is testing

Europe-Africa Research Network for Evaluation of Second-line Therapy

Who this might be right for
Human Immunodeficiency VirusHIV
Justine Boles 1,277
Testing effectiveness (Phase 2)Study completedNCT01159275
What this trial is testing

Lopinavir (LPV) Dose Reduction

Who this might be right for
HIV-1 Infections
The HIV Netherlands Australia Thailand Research Collaboration 20
Testing effectiveness (Phase 2)Study completedNCT00125983
What this trial is testing

Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 32
Next Page